ARYCX | CSEIX | ARYCX / CSEIX | |
Total Expense Ratio | 2.15 | 1.10 | 195% |
Annual Report Gross Expense Ratio | 2.15 | 1.10 | 195% |
Fund Existence | 18 years | 28 years | - |
Gain YTD | 1.002 | 4.709 | 21% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 543M | 8.3B | 7% |
Annual Yield % from dividends | 1.15 | 2.72 | 42% |
Returns for 1 year | -2.59 | -1.37 | 190% |
Returns for 3 years | 17.52 | 33.12 | 53% |
Returns for 5 years | 3.29 | 27.14 | 12% |
Returns for 10 years | -2.88 | 55.91 | -5% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BRWTX | 29.30 | N/A | N/A |
MFS Blended Research Growth Eq R3 | |||
NPSGX | 18.36 | N/A | N/A |
Nicholas Partners Small Cap Gr Instl | |||
JGYCX | 13.52 | N/A | N/A |
JHancock Global Shareholder Yield C | |||
JFNCX | 61.76 | N/A | N/A |
Janus Henderson Global Life Sciences C | |||
RICGX | 67.39 | -0.16 | -0.24% |
American Funds Invmt Co of Amer R6 |